TCL Archive Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week. May 14, 2004
TCL Archive Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease June 29, 2012
TCL Archive FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections August 18, 1978
